David Bredt
CIK 2022087 · Chief Scientific Officer · last filed 2026-02-19
David Bredt is a Chief Scientific Officer who has filed 16 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for RAPP, was dated Feb 19, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13.81M
1
16
-$2.16M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Chief Scientific Officer | 389,275 | $35.48 | $13.81M | -$2.16M | 16 | 2026-02-19 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-19 | RAPP | Mixed | −2,500 | -$235.9K | EDGAR |
| 2026-02-04 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2026-01-16 | RAPP | Sell (S) | −8,500 | -$228.1K | EDGAR |
| 2026-01-05 | RAPP | Mixed | −24,567 | -$197.3K | EDGAR |
| 2025-12-16 | RAPP | Sell (S) | −8,500 | -$255.1K | EDGAR |
| 2025-11-18 | RAPP | Sell (S) | −8,500 | -$214.1K | EDGAR |
| 2025-10-16 | RAPP | Sell (S) | −8,500 | -$219.2K | EDGAR |
| 2025-09-17 | RAPP | Sell (S) | −8,500 | -$205.6K | EDGAR |
| 2025-08-18 | RAPP | Sell (S) | −8,500 | -$127.5K | EDGAR |
| 2025-07-16 | RAPP | Sell (S) | −8,500 | -$119.0K | EDGAR |